Segments - Total Parenteral Nutrition (TPN) Bags Market by Type (Single Chamber and Multi Chamber), By Capacity (200 ml, 250 ml, 300 ml, 500 ml, 1000 ml, 2000 ml, 2500 ml, 3000 ml, 3500 ml, and 4000 ml), By Age Group (Pediatric and Adult), By Application (Oncology, Gastroenterology, Neurology, Diabetes, and Others), By Material (EVA (Ethylene Vinyl Acetate), PP (Polypropylene) and Others), By End-user (Home, Hospital & Clinic, and Others), By Distribution Channel (Offline and Online) and Region (North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa) – Global Industry Analysis, Size, Share, Trends, and Forecast- 2016-2031
The Global Total Parenteral Nutrition (TPN) Bags market was estimated at USD 561.11 Million in 2022 and is anticipated to reach USD 1,102.41 Million by 2031, expanding at a CAGR of 7.9% during the forecast period.
Total Parenteral Nutrition (TPN) is a type of nutrition support that provides a patient with all the necessary nutrients, including proteins, carbohydrates, fats, vitamins, and minerals, through an intravenous (IV) infusion. This is done by delivering a specialized solution containing these essential nutrients directly into the bloodstream through a central venous catheter.
A TPN bag is a pre-mixed container of nutrient solution that contains a carefully calibrated blend of essential nutrients, antibiotics, and other medications. The bag is designed to provide a patient with all the necessary nutrients for a specified period of time, usually 24-48 hours.
The COVID-19 pandemic has had a significant impact on the Global Total Parenteral Nutrition (TPN) Bags Market. TPN bags are essential for providing essential nutrients to patients who cannot consume food orally or through enteral feeding. The report suggests that the market is expected to recover gradually as the COVID-19 situation improves globally.
The pandemic has led to an increased demand for TPN bags due to the surge in hospitalized patients, many of whom require parenteral nutrition support. Critically ill COVID-19 patients often experience complications that make it difficult for them to consume food orally or through enteral feeding, leading to a higher need for TPN therapy.
The pandemic has disrupted global supply chains, affecting the production and distribution of TPN bags. Lockdowns, travel restrictions, and reduced workforce in manufacturing facilities have led to delays in the production and delivery of TPN bags. This has created a shortage of these essential medical supplies in some regions, particularly during the peak of the pandemic.
Due to the increased demand and supply chain disruptions, there have been fluctuations in the prices of TPN bags. Some manufacturers have increased the prices to cover the additional costs associated with the pandemic, while others have maintained stable prices to ensure accessibility for patients in need. For instance, A report by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) highlights that the pandemic has disrupted the global supply chain for medical products, including TPN bags. This disruption has led to shortages and delays in the delivery of essential medical supplies.
Government policies and public healthcare spending directly impact the availability and affordability of TPN bags. High healthcare expenditure can lead to increased access to these products for patients in need.
According to the Organization for Economic Co-operation and Development (OECD), the average healthcare expenditure, as a percentage of GDP across its member countries was 9.9% in 2019. This indicates that a significant portion of the GDP is dedicated to healthcare, which can influence the spending on advanced medical products such as TPN bags.
Rising number of product launches by key market players is expected to drive the global total parenteral nutrition bags market. For instance, in November 2020, Otsuka Holdings Co., Ltd., a pharmaceutical company, announced the launch of ENEFLUID Injection, the amino acid, glucose, electrolyte, fat, and water-soluble vitamin injection. This ENEFLUID is the first peripheral parenteral nutrition solution in Japan that combines fat and water-soluble vitamins to glucose, electrolytes, and amino acids in a dual-chamber bag. By compounding fat, more calories can be administered than the approved glucose, electrolyte, and amino acid infusions, and by compounding nine water-soluble vitamins. Furthermore, in June 2020, Fresenius Kabi UK launched product website to support healthcare professionals working in parenteral nutrition bags.
Lack of awareness regarding healthcare, diet, and proper nutrition in low- and middle-income economies such as Africa and Asia Pacific are a major factor hampering the global total parenteral nutrition bags market. Less awareness regarding nutritional products and diseases associated with nutritional deficiencies in rural areas of low- and middle-income economies in Africa and Asia Pacific due to lack of healthcare professionals. For instance, according to data published by the National Center for Biotechnology Information in March 2020, African countries have around 2.3 healthcare workers per 1,000 population.
A multipronged approach is necessary, encompassing education, public health initiatives, policy making, and community engagement to counterbalance the lack of awareness regarding healthcare, diet, and proper nutrition.
Innovations in TPN formulations can improve patient outcomes, reduce complications, and decrease healthcare costs, increasing the demand for these products is expected to drive the global market during the forecast period. For instance, in November 2021, Fresenius Kabi AG, a global healthcare company, announced the winner of its innovative JUMPstart education program and research grant. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through the mentoring, education and networking of clinicians and researchers. The grant is awarded to help to advance novel, community-led research in parenteral nutrition, to make a difference for critically ill patients.
The report on the Global Total Parenteral Nutrition (TPN) Bags market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Total Parenteral Nutrition (TPN) Bags Market– Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017–2022 |
Forecast Period |
2024–2032 |
Segmentation |
By Type (Single Chamber and Multi Chamber), By Capacity (200 ml, 250 ml, 300 ml, 500 ml, 1000 ml, 2000 ml, 2500 ml, 3000 ml, 3500 ml, and 4000 ml), By Age Group (Pediatric and Adult), By Application (Oncology, Gastroenterology, Neurology, Diabetes, and Others), By Material (EVA (Ethylene Vinyl Acetate), PP (Polypropylene) and Others), By End-user (Home, Hospital & Clinic, and Others), By Distribution Channel (Offline and Online) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered |
Baxter International Inc.; B. Braun SE; Valmed S.r.l.; Generic Specialties, Inc; INFRA S.r.l.; Paolo Gobbi Frattini S.r.l.; Kapsam Health Products; Huali Technology Co., Ltd; Vitaimed Instrument Co., Ltd.; Boen Healthcare Co., Ltd. And Others. |
Based on type, the total parenteral nutrition (TPN) bags market is segmented into single chamber and multi chamber. The single chamber segment is expected to expand at a significant pace during the forecast period, as single chamber bags are easier to use and require less manipulation compared to multi chamber bags, which reduces the risk of complications associated with line clogging or obstruction. Furthermore, these bags are cost-effective, as they do not require the use of additional materials or components to separate the different components of the TPN solution.
Based on capacity, the total parenteral nutrition (TPN) bags market is segmented into 200 ml, 250 ml, 300 ml, 500 ml, 1000 ml, 2000 ml, 2500 ml, 3000 ml, 3500 ml, and 4000 ml. The 200 ml to 1000 ml segments are expected to expand at a significant pace during the forecast period owing to the growing demand for advanced drug delivery systems, driving the need for TPN bags in various sizes to accommodate different treatment requirements and recent market analysis highlights the increasing significance of TPN bags in the parenteral nutrition, indicating a growing trend toward their adoption and utilization in various sizes. The 2000 ml, 2500 ml, 3000 ml, 3500 ml, and 4000 ml segments are anticipated to expand at a significant CAGR during the forecast period, as healthcare providers are increasingly utilizing large-volume TPN bags to meet the nutritional needs of patients requiring high fluid and nutrient intake. Advancements in manufacturing processes and materials have enabled the production of large-volume TPN bags that are safe, reliable, and compatible with a wide range of medical settings.
Based on age group, the total parenteral nutrition (TPN) bags market is segmented into pediatric and adult. The pediatric segment is expected to expand at a significant pace during the forecast period owing to the rising adoption of pediatric medical devices driven by technological advancements in pediatric devices, which enhance healthcare delivery for children. Growing awareness about the importance of pediatric care leads to an increased demand for specialized medical devices and services tailored for children, thereby propelling the segment.
Based on application, the total parenteral nutrition (TPN) bags market is segmented into oncology, gastroenterology, neurology, diabetes, and others. The gastroenterology segment is expected to expand at a significant pace during the forecast period due to the rising demand for TPN bags in gastroenterological conditions that necessitate parenteral nutrition support. Advances in healthcare technology and the development of innovative formulations and delivery methods boost the adoption of TPN bags for the treatment of the gastrointestinal tract, thereby driving the segment.
Based on material, the total parenteral nutrition (TPN) bags is segmented into EVA (Ethylene Vinyl Acetate), PP (polypropylene) and others. The EVA (Ethylene Vinyl Acetate) segment is expected to expand at a significant pace during the forecast period, owing to the high demand for environmentally-friendly materials such as EVA, which are used in TPN bags. This trend towards eco-friendly materials is promoting the development and adoption of EVA infusion bags in the healthcare sector. The demand for parenteral nourishment is high in chronic illnesses such as Crohn's disease and ulcerative colitis as well as in cases of malnutrition. This increased demand for nutritional support, including the use of TPN bags made from EVA, which is expected to drive the EVA segment in the coming years.
Based on end-user, the total parenteral nutrition (TPN) bags is segmented into home, hospital & clinic, and others. The home segment is expected to expand at a significant pace during the forecast period, as TPN bags for home parenteral nutrition (HPN) allows patients to receive essential nutrients in the comfort of their own homes. This helps them improving their quality of life and reduce the need for frequent hospital visits. Regulatory bodies and healthcare organizations are recognizing the benefits of home parenteral nutrition and providing support for its implementation, further fueling the growth of the segment.
Based on distribution channel, the total parenteral nutrition (TPN) bags is segmented into offline and online. The offline segment is expected to expand at a significant pace during the forecast period, owing to the growing demand for TPN bags in the offline settings such as hospitals and clinics. Healthcare facilities rely on TPN bags to provide essential nutrients to patients who require parenteral nutrition support and hospitals & clinics adhere to strict regulatory standards as well as safety protocols when using TPN bags for patient care. The emphasis on compliance with regulations and ensuring patient safety contributes to the growth of the offline segment.
On the basis of region, the Global Total Parenteral Nutrition (TPN) Bags market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa (MEA).
The market in North America is projected to expand at a CAGR of 8.35% during the forecast period. Manufacturers of total parenteral nutrition (TPN) bags in North America are inventing new formulations and delivery formats to cater to diverse consumer preferences. This includes the development of supplements, nutrition and multichambered products containing parenteral nutrition.
The market in Asia Pacific is expected to grow at a rapid pace during the forecast period. The increasing health consciousness among consumers, who are seeking natural and healthier alternatives to traditional medicines and supplements, is boosting the total parenteral nutrition (TPN) bags market in Asia Pacific. total parenteral nutrition is known for their high nutritional value, including protein, fiber, and essential fatty acids, which contribute to their popularity as a health supplement.
In-depth Analysis of the global Total Parenteral Nutrition (TPN) Bags Market
Historical, Current, and Projected Market Size in terms of Value
Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
Industry Drivers, Restraints, and Opportunities Covered in the Study
Recent Industry Trends and Developments
Competitive Landscape & Strategies of Key Players
Neutral Perspective on Global Total Parenteral Nutrition (TPN) Bags Market performance
Manufacturers operating in the global total parenteral nutrition (TPN) bags market include Baxter International Inc.; B. Braun SE; Valmed S.r.l.; Generic Specialties, Inc; INFRA S.r.l.; Paolo Gobbi Frattini S.r.l.; Kapsam Health Products; Huali Technology Co., Ltd; Vitaimed Instrument Co., Ltd.; Boen Healthcare Co., Ltd. And Others.
Market players are pursuing key strategies such as acquisitions, collaborations, and geographic expansion where a potential opportunity arises for the Global Total Parenteral Nutrition (TPN) Bags market.
In October 2023, Baxter International Inc. announced the launch of digital image capture capability for eye exams using its existing Welch Allyn PanOptic Plus Ophthalmoscope. The iExaminer Pro System adds a key technology to routine eye exams, designed to help advance healthcare professionals’ ability to examine and diagnose the eye health of patients.
In July, 2023, Baxter International Inc. announced the launch of PERCLOT Absorbable Hemostatic Powder in the US. PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild bleeding.
In March, 2022, B. Braun SE acquired Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates. The fully automated ECOMix mixing system developed by Intermedt enables dialysis centers to prepare the acid concentrates required for hemodialysis in a simple, flexible, and environmentally friendly manner.
In November 2021, B. Braun SE announced the partnership with REVA Medical for the distribution of Fantom Encore - a bioresorbable scaffold for coronary interventions, manufactured with REVA's patented material Tyrocore.
Additional company profiles can be provided on request. For a discussion related to the above findings, click Speak to Analyst.
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
The global Total Parenteral Nutrition (TPN) Bags market is driven by a combination of factors that are expected to fuel its growth in the coming years. One of the primary drivers is the increasing prevalence of chronic diseases, such as gastrointestinal disorders, cancer, and neurological disorders, which often require enteral nutrition.
According to this Growth Market Reports report, the Global Total Parenteral Nutrition (TPN) Bags market is likely to register a CAGR of 7.9% during the forecast period 2023-2032, with an anticipated valuation of USD 1,102.41 Million by the end of 2032.
The hospital & clinic segment holds 67.2% market value share in 2022, owing growing demand for TPN bags in hospitals and clinics for patients requiring parenteral nutrition support. Healthcare facilities rely on TPN bags to provide essential nutrients to patients who cannot consume food orally. This is expected to increase the demand for total parenteral nutrition (TPN) bags during the forecast period.
Rising GDPs of emerging economies, growth in healthcare industry, government policies, R&D activities, healthcare expenditure are expected to act as macroeconomic factors for the market.
Baxter International Inc.; B. Braun SE; Valmed S.r.l.; Generic Specialties, Inc; INFRA S.r.l.; Paolo Gobbi Frattini S.r.l.; Kapsam Health Products; Huali Technology Co., Ltd; Vitaimed Instrument Co., Ltd.; Boen Healthcare Co., Ltd. And Others.
The outbreak of coronavirus disease in 2019 (COVID-19) hampered global economy, created global interdependence, and challenged governments of many nations. The long-term effects of the pandemic are expected to hamper various industries during the forecast period, especially across Eastern Europe, the European Union, Eastern & Central Asia, and the US. The pandemic halted the manufacturing and transportation services that led to disturbance in the supply chain of various therapy’s, including global total parenteral nutrition (TPN) bags.
In addition to market size (in USD Million) company market share (in % for the base year 2023) is available in the report. Moreover, additional data analysis can be provided on request.
The base year considered for the global Total Parenteral Nutrition (TPN) Bags market report is 2022. The complete analysis period is 2021 to 2031, wherein, 2016, and 2022 are the historic years, and the forecast is provided from 2023 to 2031.